Skip to content

Roivant Sciences

US · ROIV #747 by market cap Listed 1970
34.75 -0.78 -2.20%
Live - 5344 symbols - heartbeat 65s ago · 2026-10-08 08:33
Pre-market 34.15 -1.73%
After-hours 35.06 +0.91%
Overnight 34.55 -0.58%
Market cap
25.10B
P/B
5.93
EPS
-0.54
Reader sentiment Are you bullish or bearish on ROIV?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    Guggenheim Maintains Roivant Sciences(ROIV.US) With Buy Rating, Raises Target Price to $36
    Market Newswire · 2026/5/26
  • Rating change
    J.P. Morgan Maintains Roivant Sciences(ROIV.US) With Buy Rating, Raises Target Price to $40
    Market Newswire · 2026/5/27
  • Bernstein Initiates Roivant Sciences(ROIV.US) With Buy Rating, Announces Target Price $41
    Market Newswire · 2026/9/27
  • Rating change
    A Quick Look at Today's Ratings for Roivant Sciences(ROIV.US), With a Forecast Between $34 to $42
    Market Newswire · 2026/5/22
  • Company notice
    Roivant Sciences: Roivant Sciences Ltd. - Flex Position Consolidation Option Symbol: 1ROIV
    OCC · 2026/5/11
  • Stifel Maintains Roivant Sciences(ROIV.US) With Buy Rating, Maintains Target Price $51
    Market Newswire · 2026/9/17
  • Rating change
    J.P. Morgan Maintains Roivant Sciences(ROIV.US) With Buy Rating, Maintains Target Price $40
    Market Newswire · 2026/8/10
  • Form 144 | Roivant Sciences(ROIV.US) Officer Proposes to Sell 7.32 Million in Common Stocks
    Market Newswire · 2026/10/1
  • Rating change
    Citi Maintains Roivant Sciences(ROIV.US) With Buy Rating, Raises Target Price to $46
    Market Newswire · 2026/8/10
  • Rating change
    Piper Sandler Maintains Roivant Sciences(ROIV.US) With Buy Rating, Maintains Target Price $40
    Market Newswire · 2026/8/28
  • Rating change
    H.C. Wainwright Maintains Roivant Sciences(ROIV.US) With Buy Rating, Raises Target Price to $41
    Market Newswire · 2026/8/7
  • Rating change
    TD Cowen Maintains Roivant Sciences(ROIV.US) With Buy Rating, Raises Target Price to $50
    Market Newswire · 2026/8/7
  • Rating change
    H.C. Wainwright Maintains Roivant Sciences(ROIV.US) With Buy Rating, Maintains Target Price $47
    Market Newswire · 2026/9/9
  • Stifel Initiates Roivant Sciences(ROIV.US) With Buy Rating, Announces Target Price $51
    Market Newswire · 2026/9/17
  • Rating change
    Guggenheim Maintains Roivant Sciences(ROIV.US) With Buy Rating, Raises Target Price to $42
    Market Newswire · 2026/8/7
  • Rating change
    H.C. Wainwright Maintains Roivant Sciences(ROIV.US) With Buy Rating, Maintains Target Price $41
    Market Newswire · 2026/8/28
  • J.P. Morgan Maintains Roivant Sciences(ROIV.US) With Buy Rating
    Market Newswire · 2026/9/18
  • Rating change
    J.P. Morgan Maintains Roivant Sciences(ROIV.US) With Buy Rating, Raises Target Price to $41
    Market Newswire · 2026/9/2
  • Rating change
    A Quick Look at Today's Ratings for Roivant Sciences(ROIV.US), With a Forecast Between $46 to $55
    Market Newswire · 2026/9/9
  • Rating change
    TD Cowen Maintains Roivant Sciences(ROIV.US) With Buy Rating, Maintains Target Price $55
    Market Newswire · 2026/9/10

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 08:33:07 · For reference only, not investment advice and not tailored to your situation.